Corporate DisclosureBXPHARMA
BXPHARMA Corporate Disclosure — 3 April 2018
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 3 April 2018. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
Referring to their earlier news (disseminated by DSE on 08.10.2017) regarding acquiring a majority shareholding (85.22%) in Nuvista Pharma Ltd., the Company has further informed that the Board of Directors of the Company has considered and approved the acquisition of 10,013,474 ordinary shares of Tk. 10.00 each being 85.22% shareholdings of total capital in Nuvista Pharma Limited (formerly Organon Bangladesh Limited), a leading Pharma company in Bangladesh, specializing (cont.)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616acef05a6b00004005d1d2
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.